help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRAMER, B. W.
Right arrow Articles by JOBE, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KRAMER, B. W.
Right arrow Articles by JOBE, A. H.
Am. J. Respir. Crit. Care Med., Volume 164, Number 6, September 2001, 982-988

Dose and Time Response after Intraamniotic Endotoxin in Preterm Lambs

BORIS W. KRAMER, TIMOTHY J. MOSS, KAREN E. WILLET, JOHN P. NEWNHAM, PETER D. SLY, SUHAS G. KALLAPUR, MACHIKO IKEGAMI, and ALAN H. JOBE

Division of Pulmonary Biology, Children's Hospital Medical Center, Cincinnati, Ohio; and Department of Obstetrics and Gynecology and Division of Clinical Sciences, Center for Child Health Research at the University of Western Australia, Perth, Australia



    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Intraamniotic endotoxin causes chorioamnionitis, which is followed by improved fetal lung function after 4 d in fetal sheep. We evaluated 0.1 mg, 1 mg, 4 mg, and 10 mg endotoxin for inflammation and lung maturation effects after 7 d. Four and 10 mg endotoxin caused similar lung maturation and inflammation in the lung and chorioamnion. The number of neutrophils in cord blood and the inflammatory cells in alveolar lavage and fetal lung tissue increased in a dose-dependent manner. Lower endotoxin doses induced indicators of chorioamnionitis, lung and systemic inflammation without inducing lung maturation. Therefore, some degree of inflammation can occur without subsequent lung maturation. The inflammatory changes caused by 4 mg endotoxin were assessed after 5 h, 24 h, 72 h, and 7 d to discern local versus systemic inflammation after intraamniotic endotoxin. At 5 h active inflammatory cells were in the airways producing hydrogen peroxide, and interleukin-6 and -8 were increased in the cord blood indicating both lung and systemic responses. Cells recruited into the amniotic fluid produced proinflammatory cytokine mRNA for 7 d with no cytokine mRNA in chorioamnion, lung, or spleen after 72 h. The cells in the amniotic fluid may be a source of prolonged fetal exposure to proinflammatory cytokines.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Keywords: respiratory distress syndrome; bronchopulmonary dysplasia; neutrophil recruitment; surfactant; cytokines

Prenatal exposure to inflammation/infection has been associated with numerous adverse outcomes that include preterm labor and delivery, increased risks of bronchopulmonary dysplasia (BPD), cerebral palsy, and neonatal sepsis (1). However, histological chorioamnionitis and fetal colonization with organisms such as Ureaplasma urealyticum also have been associated with a decreased incidence of respiratory distress syndrome (RDS) (4, 5), and in one epidemiological study chorioamnionitis predicted increased survival of infants born at gestations < 26 wk (6). There is very little information about how the fetus responds to intraamniotic infection/inflammation.

We have used intraamniotic injections of endotoxin to characterize the chorioamniotic and fetal lung responses to an inflammatory stimulus (7). Using a dose of 20 mg endotoxin, we found that inflammatory cells were recruited to the chorioamnion and the chorioamnion produced interleukin (IL)-1beta , IL-6, and IL-8 mRNA within 5 h (10). The expression of the mRNAs for the proinflammatory cytokines returned to control values within 2 d but inflammatory cells were increased in the chorioamnion for 25 d after the endotoxin exposure (10). The lung tissue expressed the same cytokine mRNAs within 5 h of the intraamniotic endotoxin injection but expression was higher at later time points and inflammatory cells also persisted in the lungs (10). The mRNAs for the surfactant proteins increased within 24 h of endotoxin exposure and remained increased for 15 d, although lung mechanics did not improve until 4 to 7 d after the endotoxin exposure (9). We found a minimal systemic response to the intraamniotic endotoxin. The cord blood granulocytes initially decreased and then increased moderately (10), fetal cortisol levels did not increase (11), and there was no increased cytokine expression in liver, gut, or placental tissue (10). In this study we asked whether systemic or local inflammatory changes are required for subsequent lung maturation by evaluating various endotoxin doses ranging from 0.1 mg to 10 mg, and by evaluating both the systemic and local inflammatory changes at different times after intraamniotic endotoxin injection.

    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Animals, Endotoxin, Delivery, and Postnatal Assessment

The animal component of the studies was performed in Western Australia, as approved by the animal care and use committees from Children's Hospital Medical Center, Cincinnati, OH, the Ethics Committee of the Western Australian Department of Agriculture, and the University of Western Australia. Date bred Merino ewes with a singleton fetus were randomized for the two protocols (Table 1). To evaluate the response to endotoxin dose, animals were randomized to saline, 0.1, 1, 4, or 10 mg Escherichia coli 055:B5 endotoxin (Sigma, St. Louis, MO), given 7 d before preterm delivery at 125 d gestation. To evaluate the inflammatory responses by time interval from endotoxin exposure other animals were randomized to receive 4 mg endotoxin at 5 h, 24 h, or 72 h before delivery. The endotoxin was solubilized in saline and filtered. The intraamniotic injection was given into the amniotic cavity with ultrasound guidance (8, 11). Preterm lambs were delivered at 125 d gestational age by cesarean section (12). For evaluating lung function 7 d after endotoxin exposure, the preterm lambs were ventilated for 40 min with time-cycled, pressure-limited infant ventilators (11). Peak inspiratory pressures were limited to 40 cm H2O. A pressure transducer (model 8507C-2; Endevco, San Juan Capistrano, CA) and pneumotachograph (model 35-597; Hans Rudolph, Kansas City, MO) were placed between the tracheostomy tube and the ventilator to measure tracheal pressure and flow, respectively. Volume was obtained by integrating flow (12).


                              
View this table:
[in this window]
[in a new window]
 

TABLE 1

 ENDOTOXIN DOSE AND TIME INTERVAL

Measurements on Lungs, Spleen, Plasma, and Cells from Amniotic Fluid and Alveolar Lavage Fluid

Lungs were removed and processed as described (13). The deflation limb of the pressure-volume curve was measured. Saturated phosphatidylcholine (Sat PC) (14, 15), total protein (13, 16), and surfactant proteins (Western blot) were measured (9). The mRNA for the surfactant proteins and for selected cytokines were quantified using sheep-specific probes (9, 10, 17). To reduce the high viscosity, amniotic fluid was incubated at 37° C with N-acetyl-L-cysteine, neuraminidase, and hyaluronidase. Cells from amniotic fluid and alveolar lavage fluid were isolated by centrifugation.

The right upper lobe was inflation fixed at 30 cm H2O. After hematoxylin and eosin staining the tissue was assessed for inflammatory changes (8). Hydrogen peroxide was measured in cells recovered from alveolar lavage fluid of the left lung. Flow cytometry was used to measure CD11b (alpha M subunit of integrin CR3) and CD44 (proteoglycan link protein) and the percentage of apoptotic cells was determined by annexin V and propium iodide staining (20). Enzyme-linked immunosorbent assays (ELISA) were developed for IL-6 and IL-8 with antibodies from Chemicon (Temecula, CA) and recombinant proteins as standards from CSIRO (Parkville, Australia). Interferon-gamma (IFN-gamma ) was measured by ELISA (CSL, Parkville, Australia; recombinant protein was provided by Dr. S. L. Jones, CSL).

Data Analysis

Results are given as means ± SEM. Inflammatory scores are given as medians with interquartile, 5th and 95th percentile ranges. Comparisons between endotoxin-treated and untreated lambs were by analysis of variance with Student-Newman-Keuls tests used for post-hoc analyses. Tissue scores were compared using the Mann-Whitney nonparametric tests. Significance was accepted at p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Inflammation and Lung Maturation

There were no differences between the groups in body weights or pH in cord blood (Table 1). Lung function was improved after intraamniotic injection of 4 mg and 10 mg endotoxin given 7 d prior to delivery (Figure 1). Lung gas volumes measured by deflation pressure-volume curves were increased for the 4 and 10 mg dose groups. At 40 cm H2O pressure, volumes were increased from a mean value of 11 ml/kg in control animals to 32-38 ml/kg after endotoxin exposure of 4 mg and 10 mg (Figure 1A). The compliances also were about 2-fold higher after 4 mg or 10 mg endotoxin than in control lambs (Figure 1B). The alveolar surfactant pool size was significantly increased from 0.5 µmol/kg (control) to values over 4 µmol/kg after 4 mg and 10 mg endotoxin (Figure 1C). The mRNAs for surfactant proteins A and C remained elevated 7 d after injection of 4 mg and 10 mg endotoxin (Figure 1D). The dose of 1 mg endotoxin significantly increased SP-C mRNA but not other surfactant proteins.


View larger version (30K):
[in this window]
[in a new window]
 
Figure 1.   Lung maturation and function. (A) Pressure-volume curves. After 40 min of ventilation the deflation limbs of the pressure volume curves were improved after 4 and 10 mg endotoxin. (B) Compliance after 40 min ventilation. Compliance increased after 4 mg and 10 mg endotoxin by about 2-fold. (C ) Sat PC in alveolar lavage fluid increased after 4 mg and 10 mg endotoxin. (D) mRNAs for the surfactant proteins SP-A, B, and C. The mRNAs were increased 7 d after instillation of 10 mg endotoxin, and SP-A and SP-C mRNAs were increased after 4 mg endotoxin, SP-C mRNA was increased after 1 mg endotoxin (*p < 0.05 versus control).

Indicators of Inflammation with Endotoxin Doses

The inflammatory scores in the fetal lung were increased 7 d after the intraamniotic injection of 1, 4, or 10 mg endotoxin in a dose-dependent manner (Figure 2A). The number of inflammatory cells recovered from the alveolar lavage also increased with dose (Figure 2B). The number of granulocytes and monocytes increased significantly after the 0.1 mg and higher doses of endotoxin. Therefore, inflammatory scores and inflammatory cells in alveolar lavages increased for doses of endotoxin that did not induce lung maturation. The increases were dose dependent. After 1, 4, and 10 mg endotoxin there was an increase in inflammatory cells in chorioamniotic membranes (Figure 3A). In all endotoxin-treated animals there were increased numbers of monocytes and lymphocytes in the amniotic fluid (Figure 3B). After doses of 4 mg and 10 mg there was an influx of neutrophils. The absolute number of cells increased in a dose-dependent fashion.


View larger version (24K):
[in this window]
[in a new window]
 
Figure 2.   Inflammation in the fetal lungs. (A) Inflammatory scores in the fetal lungs (airspace + tissue). Plots show median, 25th, and 75th percentile ranges as boxes and 5th to 95th percentile ranges as error bars. The numbers of inflammatory cells were ranked from few inflammatory cells (score = 1), moderate cell infiltration (score = 2), to extensive influx of cells (score = 3). Endotoxin doses of 1 mg, 4 mg, and 10 mg increased the inflammation scores. (B) Number of cells recovered from alveolar lavage. All doses of endotoxin increased monocytes and neutrophils in alveolar lavage. The number of lymphocytes was increased after doses of 4 mg and 10 mg (*p < 0.05 versus control).


View larger version (25K):
[in this window]
[in a new window]
 
Figure 3.   Inflammatory cells in fetal membranes and amniotic fluid. (A) Plots show median, 25th, and 75th percentile ranges as boxes and 5th to 95th percentile ranges as error bars. Membranes of control animals had few inflammatory cells and animals treated with 1 mg or higher endotoxin doses had an extensive influx of cells (score = 3). Most of the inflammatory cells were neutrophils. (B) Number and type of inflammatory cells in amniotic fluid. The number of inflammatory cells increased after all doses of endotoxin (*p < 0.05 versus control).

The white blood cells increased in cord blood 7 d after the 4 mg and 10 mg endotoxin doses (Figure 4A). The neutrophils were the cell type that accounted for most of the increase in cord blood white cells, and the neutrophils were also increased in the animals treated with a dose of 1 mg after 7 d (Figure 4B). The increases in white blood cells and neutrophils were dose dependent. The number of platelets increased in all groups after the 7 day exposure interval, including in the animals that received 0.1 mg endotoxin (Figure 4C).


View larger version (24K):
[in this window]
[in a new window]
 
Figure 4.   Effect of intraamniotic endotoxin on white blood cells and platelets in cord blood. (A) Doses of 4 mg and 10 mg endotoxin caused an increase in white blood cells after 7 d. (B) The number of circulating neutrophils increased in a dose-dependent manner after 1 mg and higher doses of endotoxin. (C ) The number of platelets increased in every group of animals treated with endotoxin. (D) The number of white blood cells decreased after 24 h and increased at 7 d. (E ) The circulating neutrophils increased at 7 d. (F ) The number of platelets was elevated only 7 d after endotoxin (*p < 0.05 versus control).

Time Interval for Inflammatory Response

For the animals studied at different time intervals after 4 mg endotoxin the number of total white blood cells in cord blood decreased at 24 h because the lymphocytes decreased and subsequently increased at 7 d due to increased granulocytes (Figure 4D and 4E). The increase in platelets occurred only 7 d after the 4 mg dose of endotoxin (Figure 4F). The increases in cord blood white cells and platelets were late events after endotoxin exposure.

In contrast, inflammatory cytokine mRNAs for IL-1beta , IL-6, IL-8, and tumor necrosis factor-alpha (TNF-alpha ) increased in the chorioamnion within 5 h after intraamniotic endotoxin (Figure 5A). The 3- to 7-fold increases were the highest at 5 h. The increase in expression of TNF-alpha mRNA was not large at any time, and the expression of IL-10 mRNA in chorioamnion did not change at any time. An increase in inflammatory cells in the amniotic fluid occured by 5 h after the intraamniotic endotoxin and was highest at 72 h (Figure 5C). The cells recovered from the amniotic fluid had a different time pattern of cytokine mRNA expression than did the chorioamnion (Figure 5B). The expression of IL-1beta mRNA increased at 24 h and remained elevated at 7 d, IL-8 mRNA was increased at 72 h and 7 d, and IL-6 mRNA did not increase.


View larger version (33K):
[in this window]
[in a new window]
 
Figure 5.   Cytokine mRNA in fetal membranes and cells from amniotic fluid. (A) IL-1beta , IL-6, IL-8, and TNF-alpha mRNAs were increased in the chorioamnion at 5 h and 24 h. IL-10 mRNA was not increased at any time. (B) IL-1beta and IL-8 mRNA increased at 24 h, and 72 h and 7 d in cells from amniotic fluid. (C ) The number of monocytes, lymphocytes, and neutrophils in amniotic fluid increased at 5 h and remained increased at all time points (*p < 0.05 versus control).

Inflammatory cells were recruited into the alveolar lavage by 5 h, and peaked at 72 h (Figure 6A). IL-1beta , IL-8, and TNF-alpha mRNAs were increased in lung tissue only 24 h after endotoxin exposure (Figure 6B). The mRNAs for IL-1beta and IL-8 were increased in the alveolar cells recruited to the airways at 24 h and 72 h (Figure 6C). Surfactant protein mRNAs for SP-D was increased 5 h after 4 mg endotoxin and at all later time points (Figure 6D). SP-A, B, and C mRNA were increased 24 h after endotoxin exposure. Activation of cells recruited to the airways was assessed by measuring the expression of the adhesion molecules (CD11b and CD44) (Figure 7, A and B). The percentage of positive cells increased at 5 h and was highest at 72 h for both cell surface markers. The numbers of apoptotic and necrotic cells per body weight in the alveolar lavage also were the highest at 72 h after endotoxin (Figure 7, C and D). The cells recruited to the airways at 5 h were highly active based on the amount of hydrogen peroxide per cell (Figure 7E). However, relative to the number of cells recruited to the airways, the total amount of hydrogen peroxide normalized to body weight was highest at 24 h (Figure 7F).


View larger version (38K):
[in this window]
[in a new window]
 
Figure 6.   Cells in alveolar lavage, cytokine mRNAs in cells from alveolar lavage and lung, and surfactant protein mRNAs in lung tissues. (A) The number of monocytes and neutrophils in alveolar lavage increased after 5 h and remained increased to 7 d. (B) At 24 h IL-1beta , IL-8, and TNF-alpha mRNA were elevated in mRNA from lung tissue. (C ) The IL-1beta and IL-8 mRNA from cells recovered from alveolar lavage increased at 24 h and 72 h. (D) Time course of induction of surfactant protein mRNAs increased after 4 mg endotoxin. The SP-D mRNA was induced after 5 h, the mRNAs of all were increased after 24 h (*p < 0.05 versus control).


View larger version (27K):
[in this window]
[in a new window]
 
Figure 7.   Markers of activation of cells from alveolar lavage. (A) Percent of CD11b (alpha M subunit of integrin CR3) positive cells. The number of CD11b positive cells increased from 5 h to 72 h. (B) The percentage of CD44 (proteoglycan link protein) positive cells also increased from 5 h to 72 h. (C, D) The number of apoptoic cells in the alveolar lavage was determined by annexin V staining and counterstaining with propium iodide to detect necrotic cells. The numbers of apoptotic and necrotic cells were highest at 72 h. (E ) The production of hydrogen peroxide per 106 cells was maximal after 5 h. (F ) The production of hydrogen peroxide per kilogram body weight was highest at 24 h when the total cell number in the alveolar lavage was also most elevated (*p < 0.05 versus control).

Septemic Inflammation

Several variables were measured to evaluate the systemic inflammation. In cord blood plasma IFN-gamma was increased 12-fold at 24 h (Figure 8A). IL-6 was increased significantly at 5 h (Figure 8A). IL-8 was increased from 5 h to 7 d by about 3-fold, and IL-8 was the only cytokine that was elevated at all time points measured. The expression of TNF-alpha mRNA increased 2-fold at 24 h in spleen tissue (Figure 8B). However, the overall cytokine expression pattern indicates minimal cytokine production by the spleen.


View larger version (33K):
[in this window]
[in a new window]
 
Figure 8.   Systemic inflammation. (A) Interferon gamma (IFN-gamma ) was increased in cord plasma at 24 h. Interleukin-6 was increased at 5 h and interleukin-8 was increased from 5 h to 7 d. (B) The amount of IL-1beta , IL-6, IL-8, and IL-10 mRNA in the spleen did not increase. The amount of TNF-alpha increased by 2-fold at 24 h only (*p < 0.05 versus control).

    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

We have shown that there was no lung maturation-as indicated by increased lung gas volume, improved compliance, and increased surfactant Sat PC and increased SP mRNAs-without preceding inflammation in chorioamnion and fetal lung using various doses of endotoxin. On the other hand, mild inflammation was not followed by lung maturation. The lower doses of 0.1 mg and 1 mg endotoxin induced an influx of inflammatory cells into the chorioamnion, the amniotic fluid, lung tissue, and alveolar lavages that persisted 7 d after endotoxin exposure but lung function was not improved. The increases in white blood cells and inflammatory cells in fetal lung and alveolar lavage were dose dependent. Even the lowest dose of endotoxin induced an increase in cells in amnoitic fluid and in platelets indicating a subtle systemic response to the inflammatory stimulus given into the amniotic fluid.

The inflammatory response in the fetal lungs and cord blood increased with endotoxin dose, suggesting that a threshold amount of inflammation was needed to induce the improved lung function. A distinction between local and systemic inflammatory response could not be made after 7 d. We previously found endotoxin doses of 1, 4, 20, or 100 mg caused equivalent maturational exposure without increases in fetal cortisol (11). The variability of response to 1 mg endotoxin may be attributed to the variation in endotoxin preparations. In the fetal sheep model, a dose of 1 or 4 mg given by intraamniotic injection is the minimal stimulus needed to enhance lung function after preterm delivery. There was a clear dose- response relationship between inflammation and the amount of endotoxin. However there were no clearly graded or partial lung maturation responses.

In a previous study we found that 20 mg endotoxin given by intraamniotic injection increased IL-1beta , IL-6, and IL-8 mRNA in the chorioamnion at 5 h with a parallel response in the lungs beginning at 5 h that increased for about 2 d (10). For this study we used the minimal effective dose of 4 mg endotoxin for inducing lung maturation and addressed the question whether systemic versus local inflammation in the fetus was induced by intraamniotic endotoxin and which compartment was producing proinflammatory cytokines at later time points. The mRNAs for IL-1beta , IL-6, IL-8, and TNF-alpha were most increased at 5 h in the chorioamnion. Inflammatory cells in the amniotic fluid were increased at 5 h, but the 40-fold increase in granulocytes was at 24-72 h, and the up to 35-fold increases in IL-1beta and IL-8 mRNA occurred over the 24 h to 7 day interval, with no increase in IL-6 mRNA. The distinct differences between chorioamnion and cells in amniotic fluid suggest that the inflammation in amniotic fluid was regulated differently from the response of the chorioamnion. The cytokine response continued in amniotic fluid after it was extinguished in the chorioamnion and fetal lungs.

The mRNAs for the proinflammatory cytokines were increased in lung and alveolar lavage by 24 h, but not at 5 h as noted previously with the higher endotoxin dose (10). The first detectable effect of inflammation in the lungs was the large increase in H2O2 production by the few cells recruited by 5 h. At the same time the mRNA for SP-D was increased. The large number of cells in alveolar lavages at 72 h expressed the surface adhesion molecules CD11b and CD44, which mediate cell recruitment to sites of inflammation. Although the cell surface antigens indicate that many cells evaluated at 72 h were quickly recruited to the airways, they were no longer producing H2O2. We used the measurements of annexin V and counterstaining with propium iodide to evaluate the percentage of apoptotic and necrotic cells in the cell population. Because the total cell numbers increased, we calculated the number of necrotic and apoptotic cells per kilogram body weight, which should best reflect the timing of resolution of inflammation in the lungs. The high numbers of apoptotic and necrotic cells at 72 h indicated resolution of inflammation at 72 h (21). However, complete resolution had not occurred by 7 d, and we found residual inflammatory cells in alveolar lavage as long as 25 d after intraamniotic endotoxin (10).

None of the indicators of inflammation that were detected at 7 days correlated very well with the improved lung function after preterm delivery. Early indicators such as H2O2 and cytokine production in the chorioamnion and the lung cannot be evaluated because those indicators have been extinguished before the physiological maturation response occurs. In mature lungs, endotoxin and proinflammatory cytokines initially suppress the mRNAs for surfactant proteins and the surfactant proteins can rebound to higher levels than normal with healing (17, 22). Although detectable, the mRNAs for SP-A and SP-B are very low at 125 d gestation in the fetal sheep lung, and no decreases are seen after intraamniotic endotoxin. SP-C mRNA should be the most sensitive indicator because it is relatively high at 125 d gestation, and it is unchanged 5 h and increased 24 h after intraamniotic endotoxin. Inflammatory cells producing H2O2 and cytokines were accumulating in the lungs over 3 d, providing a source for direct lung injury. The wet-to-dry weights did not change from control values nor did the total protein in the alveolar lavages (data not shown). However, the antioxidant enzymes catalyse, glutathione peroxidase, and superoxide dismutase are induced after endotoxin exposure, indicating activation of oxidant-mediated pathways in the fetal lung (23). SP-A and SP-D may function as antioxidants (24). SP-D mRNA was increased within 5 h. A hypothesis for the events that result in lung maturation after intraamniotic endotoxin is that neutrophils producing oxidants cause a primary injury and that the fetal lung responds with lung maturation as a protective response.

We previously found that 20 mg intraamniotic endotoxin did not increase proinflammatory cytokine mRNA in the placenta, fetal liver, or fetal gut. We used the lower dose of 4 mg endotoxin to search for other indicators of a systemic inflammatory response. The TNF-alpha mRNA increased by about 2-fold at 24 h only in the spleen, with no increase in IL-1beta , IL-6, or IL-8, indicating a very minimal response from the fetal spleen. In preterm lambs that were treated with intratracheal endotoxin the spleen produced high amounts of proinflammatory cytokines within 6 h demonstrating that the preterm spleen can respond to a proinflammatory stimulus (25). Nevertheless, IL-6 and IL-8 were increased in cord plasma over the extended interval from 24 h to 7 d. Interferon-gamma also was increased in plasma 12-fold at 24 h. Using IL-8 as a representative proinflammatory cytokine, we found no increases in mRNA at 72 h or 7 d in chorioamnion, lung, or spleen. However, the mRNA for IL-8 was elevated in cells in amniotic fluid at 72 h and 7 d, suggesting that the amniotic fluid is the source of the increased cytokine in the cord plasma. As with the other components of the inflammatory response, we cannot specifically link the increased plasma cytokines at 5 h and 24 h to the lung maturation response.

The interpretation of this in vivo model relative to clinical settings is complex. The preterm human fetus at risk of delivering before 30 wk gestational age may be continuously exposed to live organisms, their products, and inflammatory mediators and the exposure may be prolonged (1). The kinetics and dynamics of chorioamniotis caused by live organisms are probably quite different from a single dose of endotoxin from gram-negative bacteria. The most common microorganism associated with chorioamnionitis is Ureaplasma urealyticum, which does not have a cell wall but induces IL-1beta , IL-6, and TNF-alpha in amniotic fluid (26). In the clinical literature cord plasma elevations of IL-6 have been used to diagnose systemic inflammation in the fetus (27, 28). We found that there were subtle indications of systemic inflammation after intraamniotic injection of endotoxin. The increase of IL-6 in cord plasma within 5 h after intraamniotic endotoxin showed that the systemic inflammation was present at the same time as the local inflammation in chorioamnion and fetal lung. However, the animals were not injured in any way that was evident by the endotoxin exposure (8, 9, 11). The antiinflamatory cytokine protein IL-10 was not detectable but sustained increases in IL-8 were in airway samples from infants that developed BPD (29). We found no significant induction of IL-10 mRNA in membranes, in lung, or in spleen. IL-8 was increased in plasma at all time points after intraamniotic endotoxin in the fetal sheep. Increased cytokine proteins in cord blood were reported in clinical studies to be associated with subsequent BPD or cerebral palsy (3, 28) and interferons can cause cerebral palsy when given to infants (30). The pattern of cytokine responses in the fetal sheep-elevated IL-8 and IFN-gamma with no induction of the antiinflammatory cytokine IL-10-parallels the clinical observations that have been associated with poor lung and neurodevelopmental outcomes (2, 31). In clinical studies oxidative injury has been implicated in the development of BPD after preterm birth (3). In our animal model the response of the fetal lung to intraamniotic endotoxin may be different because the oxidant stress is of short duration.

In summary, we found that intraamniotic doses of 0.1 mg and 1 mg endotoxin induced inflammatory cell recruitment to the chorioamnion and the lungs. However, this inflammation was not accompanied by physiological improvements in lung function. Higher doses of endotoxin sufficient to induce lung maturation were accompanied by systemic inflammation in the fetus within 5 h. Activated cells in the airways producing hydrogen peroxide within 5 h might cause an initial lung injury. Fetal exposure to sufficient inflammation can therefore induce lung maturation, but the precise link between the components and the intensity of the inflamatory response and lung maturation remains elusive.

    Footnotes

Correspondence and requests for reprints should be addressed to Alan H. Jobe, M.D., Ph.D., Children's Hospital Medical Center, Division of Pulmonary Biology, 3333 Burnet Avenue, Cincinnati, OH 45229-3039. E-mail: jobea0{at}chmcc.org

(Received in original form March 13, 2001).

This article has an onlline data supplement, which is accessible from this issue's table of contents online at www.atsjournals.org

Acknowledgments: This study was supported by NIH Grant HL-65397, the Women and Infants Research Foundation funding of infrastructural support, and a scholarship from the Deutsche Forschungsgemeinschaft to B. W. K. Commonwealth Scientific and Industrial Research Organisation, Parkville, Australia, provided recombinant ovine interleukin-6 and -8. Dr. S. L. Jones, CSL, Park Ville, Australia, kindly provided recombinant bovine interferon gamma. The probe for SP-D was a kind gift of Dr. M. Hallman, University of Oulu, Finland.
    References
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000; 342: 1500-1507 [Free Full Text].

2. Nelson KB, Dambrosia JM, Grether JK, Phillips TM. Neonatal cytokines and coagulation factors in children with cerebral palsy. Ann Neurol 1998; 44: 665-675 [Medline].

3. Speer CP, Groneck P. Oxygen radicals, cytokines, adhesion molecules and lung injury in neonates. Semin Neonatol 1998; 3: 219-228 .

4. Watterberg KL, Demers LM, Scott SM, Murphy S. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics 1996; 97: 210-215 [Abstract/Free Full Text].

5. Hannaford K, Todd DA, Jefferey H, John E, Byth K, Gilbert GL. Role of Ureaplasma urealyticum in lung disease of prematurity. Arch Dis Child Fetal Neonatal Ed 1999; 81: F162-F167 [Abstract/Free Full Text].

6. Costeloe K, Hennessey E, Gibson AT, Marlow N, Wilkinson AR. The EPICure study: outcomes to discharge from hospital for infants born after the threshold of viability. Pediatrics 2000; 106: 659-671 [Abstract/Free Full Text].

7. Willet KE, Jobe AH, Ikegami M, Brennan S, Newnham J, Sly PD. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr Res 2000; 48: 782-788 [Medline].

8. Jobe AH, Newnham JP, Willet KE, Sly P, Ervin MG, Bachurski CJ, Possmayer F, Hallman M, Ikegami M. Antenatal endotoxin and glucocorticoid effects on the lungs of preterm lambs. Am J Obstet Gynecol 2000; 182: 401-408 [Medline].

9. Bachurski CJ, Ross GF, Ikegami M, Kramer BW, Jobe AH. Intra-amniotic endotoxin increases pulmonary surfactant proteins and induces SP-B processing in fetal sheep. Am J Physiol 2001; 280: L279-L285 [Abstract/Free Full Text].

10. Kallapur SG, Willet KE, Jobe AH, Ikegami M, Bachurski CJ. Intra-amniotic endotoxin: chorioamnionitis precedes lung maturation in preterm lambs. Am J Physiol 2001; 280: L527-L536 [Abstract/Free Full Text].

11. Jobe AH, Newnham JP, Willet KE, Moss TJ, Ervin MG, Padbury JF, Sly P, Ikegami M. Endotoxin-induced lung maturation in preterm lambs is not mediated by cortisol. Am J Respir Crit Care Med 2000; 162: 1656-1661 [Abstract/Free Full Text].

12. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med 1997; 156: 178-184 [Abstract/Free Full Text].

13. Wada K, Jobe AH, Ikegami M. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J Appl Physiol 1997; 83: 1054-1061 [Abstract/Free Full Text].

14. Mason RJ, Nellenbogen J, Clements JA. Isolation of disaturated phosphatidylcholine with osmium tetroxide. J Lipid Res 1976; 17: 281-284 [Abstract].

15. Bartlett GR. Phosphorous assay in column chromatography. J Biol Chem 1959; 234: 466-468 [Free Full Text].

16. Davis AJ, Jobe AH, Häfner D, Ikegami M. Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med 1998; 157: 553-559 [Abstract/Free Full Text].

17. Bachurski CJ, Pryhuber GS, Glasser SW, Kelly SE, Whitsett JA. Tumor necrosis factor-alpha inhibits surfactant protein C gene transcription. J Biol Chem 1995; 270: 19402-19407 [Abstract/Free Full Text].

18. Young AJ, Hay JB, Chan JYC. Primary structure of ovine tumor necrosis alpha cDNA. Nucleic Acids Res 1990; 18: 6723-6732 [Free Full Text].

19. Martin H, Nash A, Andrews A. Cloning and characterisation of an ovine interleukin-10-encoding cDNA. Gene 1995; 159: 187-191 [Medline].

20. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometry detection of phosphatidylserine expression on early apoptotic cells using fluorescin labeled Annexin V.  J Immunol Methods 1995; 184: 39-51 [Medline].

21. Mann CL, Cidloski JA. Signaling cascades of apoptosis. In: Winkler JD, editor. Apoptosis and inflammation. Basel: Birkhäuser, 1999; p. 7-18.

22. Pryhuber GS, Bachurski C, Hirsch R, Bacon A, Whitsett JA. Tumor necrosis factor-alpha decreases surfactant protein B mRNA in murine lung. Am J Physiol 1996; 270: L714-L721 [Abstract/Free Full Text].

23. Sosenko IRS, Jobe AH. Intraamniotic endotoxin: promotion of lung antioxidant enzyme activity in preterm lambs precedes maturation of lung function and surfactant [abstract]. Pediatr Res 2001; 49: 383A .

24. Bridges JP, Davis HW, Damodarasamy M, Kuroki Y, Howles G, Hui DY, McCormack FX. Pulmonary surfactant proteins A and D are potent endogenous inhibitors of lipid peroxidation and oxidative injury. J Biol Chem 2000; 275: 38848-38855 [Abstract/Free Full Text].

25. Kramer BW, Jobe AH, Ikegami M. Systemic inflammation following intratracheal endotoxin that leaks into the circulation despite gentle ventilation of preterm lambs [abstract]. Am J Respir Crit Care Med 2001; 163: A209 .

26. Yoon BH, Romero R, Park JS, Chang JW, Kim YA, Kim JC, Kim KS. Microbial invasion of the amniotic cavity with Ureaplasma urealyticum is associated with a robust host in fetal, amniotic, and maternal compartments. Am J Obstet Gynecol 1998; 179: 1254-1260 [Medline].

27. Yoon BH, Romero R, Kim KS, Park JS, Ki SH, Kim BI, Jun JK. A systemic fetal inflammatory response and the development of bronchopulmonary dysplasia. Am J Obstet Gynecol 1999; 179: 1254-1260 .

28. Gomez R, Romero R, Ghezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202 [Medline].

29. Jones CA, Cayabyab RG, Kwong KYC, Stotts C, Wong B, Hamdan H, Minoo P, deLemos RA. Undetectable interleukin (IL)-10 and persistent IL-8 expression early in hyaline membrane disease: a possible development basis for the predisposition to chronic lung inflammation in preterm newborns. Pediatr Res 1996; 39: 966-975 [Medline].

30. Barlow CF, Priebe CJ, Mulliken JB, Barnes PD, MacDonald D, Folkman J, Ezekowitz RA. Spastic diplegia as a complication of interferon alpha-2a treatment of hemangiomas in infancy. J Pediatr 1998; 132: 527-530 [Medline].

31. Grether JK, Nelson KB, Dambrosia JM, Phillips TM. Interferons and cerebral palsy. J Pediatr 1999; 134: 324-332 [Medline].





This article has been cited by other articles:


Home page
J Child NeurolHome page
D. D. Jenkins, E. Chang, and I. Singh
Neuroprotective Interventions: Is It Too Late?
J Child Neurol, September 1, 2009; 24(9): 1212 - 1219.
[Abstract] [PDF]


Home page
Innate ImmunityHome page
B. W. Kramer, S. G. Kallapur, T. J. Moss, I. Nitsos, J. P. Newnham, and A. H. Jobe
Intra-amniotic LPS modulation of TLR signaling in lung and blood monocytes of fetal sheep
Innate Immunity, April 1, 2009; 15(2): 101 - 107.
[Abstract] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
F.-C. Cheah, J. J. Pillow, B. W. Kramer, G. R. Polglase, I. Nitsos, J. P. Newnham, A. H. Jobe, and S. G. Kallapur
Airway inflammatory cell responses to intra-amniotic lipopolysaccharide in a sheep model of chorioamnionitis
Am J Physiol Lung Cell Mol Physiol, March 1, 2009; 296(3): L384 - L393.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. G. Kallapur, A. H. Jobe, M. K. Ball, I. Nitsos, T. J. M. Moss, N. H. Hillman, J. P. Newnham, and B. W. Kramer
Pulmonary and Systemic Endotoxin Tolerance in Preterm Fetal Sheep Exposed to Chorioamnionitis
J. Immunol., December 15, 2007; 179(12): 8491 - 8499.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
N. H. Hillman, T. J. M. Moss, S. G. Kallapur, C. Bachurski, J. J. Pillow, G. R. Polglase, I. Nitsos, B. W. Kramer, and A. H. Jobe
Brief, Large Tidal Volume Ventilation Initiates Lung Injury and a Systemic Response in Fetal Sheep
Am. J. Respir. Crit. Care Med., September 15, 2007; 176(6): 575 - 581.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. W. Kramer, S. N. Joshi, T. J. M. Moss, J. P. Newnham, R. Sindelar, A. H. Jobe, and S. G. Kallapur
Endotoxin-induced maturation of monocytes in preterm fetal sheep lung
Am J Physiol Lung Cell Mol Physiol, August 1, 2007; 293(2): L345 - L353.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. Kunzmann, C. P. Speer, A. H. Jobe, and B. W. Kramer
Antenatal inflammation induced TGF-beta1 but suppressed CTGF in preterm lungs
Am J Physiol Lung Cell Mol Physiol, January 1, 2007; 292(1): L223 - L231.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
I. Nitsos, S. M. Rees, J. Duncan, B. W. Kramer, R. Harding, J. P. Newnham, and T. J. M. Moss
Chronic Exposure to Intra-Amniotic Lipopolysaccharide Affects the Ovine Fetal Brain
Reproductive Sciences, May 1, 2006; 13(4): 239 - 247.
[Abstract] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
S G Kallapur and A H Jobe
Contribution of inflammation to lung injury and development.
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2006; 91(2): F132 - F135.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. G. Kallapur, T. J. M. Moss, M. Ikegami, R. L. Jasman, J. P. Newnham, and A. H. Jobe
Recruited Inflammatory Cells Mediate Endotoxin-induced Lung Maturation in Preterm Fetal Lambs
Am. J. Respir. Crit. Care Med., November 15, 2005; 172(10): 1315 - 1321.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Kallapur, I. Nitsos, T. J. M. Moss, B. W. Kramer, J. P. Newnham, M. Ikegami, and A. H. Jobe
Chronic endotoxin exposure does not cause sustained structural abnormalities in the fetal sheep lungs
Am J Physiol Lung Cell Mol Physiol, May 1, 2005; 288(5): L966 - L974.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. W. Kramer, M. Ikegami, T. J. M. Moss, I. Nitsos, J. P. Newnham, and A. H. Jobe
Endotoxin-induced Chorioamnionitis Modulates Innate Immunity of Monocytes in Preterm Sheep
Am. J. Respir. Crit. Care Med., January 1, 2005; 171(1): 73 - 77.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Kallapur, C. J. Bachurski, T. D. L. Cras, S. N. Joshi, M. Ikegami, and A. H. Jobe
Vascular changes after intra-amniotic endotoxin in preterm lamb lungs
Am J Physiol Lung Cell Mol Physiol, December 1, 2004; 287(6): L1178 - L1185.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. C. Land and F. Darakhshan
Thymulin evokes IL-6-C/EBP{beta} regenerative repair and TNF-{alpha} silencing during endotoxin exposure in fetal lung explants
Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L473 - L487.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Ikegami, S. G. Kallapur, and A. H. Jobe
Initial responses to ventilation of premature lambs exposed to intra-amniotic endotoxin 4 days before delivery
Am J Physiol Lung Cell Mol Physiol, March 1, 2004; 286(3): L573 - L579.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
S. Rounioja, J. Rasanen, V. Glumoff, M. Ojaniemi, K. Makikallio, and M. Hallman
Intra-amniotic lipopolysaccharide leads to fetal cardiac dysfunction: A mouse model for fetal inflammatory response
Cardiovasc Res, October 15, 2003; 60(1): 156 - 164.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
M. Ikegami, T. J. M. Moss, S. G. Kallapur, N. Mulrooney, B. W. Kramer, I. Nitsos, C. J. Bachurski, J. P. Newnham, and A. H. Jobe
Minimal lung and systemic responses to TNF-{alpha} in preterm sheep
Am J Physiol Lung Cell Mol Physiol, July 1, 2003; 285(1): L121 - L129.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. G. Kallapur, B. W. Kramer, T. J. M. Moss, J. P. Newnham, A. H. Jobe, M. Ikegami, and C. J. Bachurski
Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs
Am J Physiol Lung Cell Mol Physiol, April 1, 2003; 284(4): L633 - L642.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. G. Kallapur, A. H. Jobe, M. Ikegami, and C. J. Bachurski
Increased IP-10 and MIG Expression after Intra-amniotic Endotoxin in Preterm Lamb Lung
Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 779 - 786.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. W. Kramer, S. Kramer, M. Ikegami, and A. H. Jobe
Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin
Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L452 - L459.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
T. J. M. Moss, M. G. Davey, R. Harding, and J. P. Newnham
Effects of Intra-Amniotic Endotoxin on Lung Structure and Function Two Months After Term Birth in Sheep
Reproductive Sciences, July 1, 2002; 9(4): 220 - 225.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
D. Warburton
Sound the Tocsin! Beware Adverse Effects of Lung Inflammation Early in Gestation
Am. J. Respir. Crit. Care Med., March 15, 2002; 165(6): 741 - 742.
[Full Text] [PDF]


Home page
Reproductive SciencesHome page
I. Nitsos, T. J. M. Moss, M. L. Cock, R. Harding, and J. P. Newnham
Fetal Responses to Intra-Amniotic Endotoxin in Sheep
Reproductive Sciences, March 1, 2002; 9(2): 80 - 85.
[Abstract] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. J. TOBIN
Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001
Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630.
[Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
B. W. KRAMER, M. IKEGAMI, and A. H. JOBE
Intratracheal Endotoxin Causes Systemic Inflammation in Ventilated Preterm Lambs
Am. J. Respir. Crit. Care Med., February 15, 2002; 165(4): 463 - 469.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Online Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KRAMER, B. W.
Right arrow Articles by JOBE, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KRAMER, B. W.
Right arrow Articles by JOBE, A. H.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 2001 American Thoracic Society